| 創建日期 | 上櫃日期 | 董事長 | 總經理 |
|---|---|---|---|
| 69/06/02 | 102/10/31 | 傅輝東 | 彪士偉 |
| EPS | 本益比 | 股價淨值比 | 現金殖利率 |
| 0.27(Q2) | 25.05 | 0.91 | 2.82% |
| 實收資本額 | 已發行普通股 | ||
| 745,743,550 | 74,574,355 | ||
| 主要經營業務 | |||
| 處方用藥、指示用藥、健康消費品之銷售推廣處方用藥及指示用藥之經銷物流服務 | |||
| 公司網址 | |||
| arich.com.tw | |||
久裕(4173) 月營收報表
| 年度/月份 | 營業收入（單位：千元） | 累計營業收入（單位：千元） | |||||
|---|---|---|---|---|---|---|---|
| 單月營收 | 去年同月營收 | 單月月增率 | 單月年增率 | 累計營收 | 去年累計營收 | 累積年增率 | |
| 2023/08 | 112,366 | 103,287 | 37.7% | 8.8% | 752,084 | 675,718 | 11.3% |
| 2023/07 | 81,578 | 76,763 | -23.9% | 6.3% | 639,718 | 572,431 | 11.8% |
| 2023/06 | 107,237 | 80,762 | 9.9% | 32.8% | 558,140 | 495,668 | 12.6% |
| 2023/05 | 97,604 | 86,822 | 9% | 12.4% | 450,903 | 414,906 | 8.7% |
| 2023/04 | 89,538 | 73,608 | -2% | 21.6% | 353,299 | 328,084 | 7.7% |
| 2023/03 | 91,347 | 89,913 | 1.1% | 1.6% | 263,761 | 254,476 | 3.6% |
| 2023/02 | 90,374 | 70,010 | 10.1% | 29.1% | 172,414 | 164,563 | 4.8% |
| 2023/01 | 82,040 | 94,553 | -15.9% | -13.2% | 82,040 | 94,553 | -13.2% |
| 2022/12 | 97,606 | 96,377 | 13% | 1.3% | 1,018,023 | 945,661 | 7.7% |
| 2022/11 | 86,342 | 80,604 | 16% | 7.1% | 920,417 | 849,284 | 8.4% |
| 2022/10 | 74,446 | 67,063 | -11.3% | 11% | 834,075 | 768,680 | 8.5% |
| 2022/09 | 83,911 | 77,712 | -18.8% | 8% | 759,629 | 701,617 | 8.3% |
| 2022/08 | 103,287 | 86,925 | 34.5% | 18.8% | 675,718 | 623,905 | 8.3% |
| 2022/07 | 76,763 | 64,426 | -4.9% | 19.1% | 572,431 | 536,980 | 6.6% |
| 2022/06 | 80,762 | 76,065 | -7% | 6.2% | 495,668 | 472,554 | 4.9% |
| 2022/05 | 86,822 | 84,664 | 18% | 2.5% | 414,906 | 396,489 | 4.6% |
| 2022/04 | 73,608 | 70,212 | -18.1% | 4.8% | 328,084 | 311,825 | 5.2% |
| 2022/03 | 89,913 | 77,455 | 28.4% | 16.1% | 254,476 | 241,614 | 5.3% |
| 2022/02 | 70,010 | 73,834 | -26% | -5.2% | 164,563 | 164,158 | 0.2% |
| 2022/01 | 94,553 | 90,324 | -1.9% | 4.7% | 94,553 | 90,324 | 4.7% |
| 2021/12 | 96,377 | 70,941 | 19.6% | 35.8% | 945,661 | 1,251,395 | -24.4% |
| 2021/11 | 80,604 | 85,536 | 20.2% | -5.8% | 849,284 | 1,180,454 | -28% |
| 2021/10 | 67,063 | 146,551 | -13.7% | -54.2% | 768,680 | 1,094,918 | -29.8% |
| 2021/09 | 77,712 | 80,501 | -10.6% | -3.5% | 701,617 | 948,367 | -26% |
| 2021/08 | 86,925 | 106,259 | 34.9% | -18.2% | 623,905 | 867,866 | -28.1% |
| 2021/07 | 64,426 | 91,217 | -15.3% | -29.4% | 536,980 | 761,607 | -29.5% |
| 2021/06 | 76,065 | 80,362 | -10.1% | -5.3% | 472,554 | 670,390 | -29.5% |
| 2021/05 | 84,664 | 96,717 | 20.6% | -12.5% | 396,489 | 590,028 | -32.8% |
| 2021/04 | 70,212 | 102,667 | -9.4% | -31.6% | 311,825 | 493,312 | -36.8% |
| 2021/03 | 77,455 | 120,886 | 4.9% | -35.9% | 241,614 | 390,645 | -38.1% |
| 2021/02 | 73,834 | 159,772 | -18.3% | -53.8% | 164,158 | 269,758 | -39.1% |
| 2021/01 | 90,324 | 109,986 | 27.3% | -17.9% | 90,324 | 109,986 | -17.9% |
| 2020/12 | 70,941 | 96,297 | -17.1% | -26.3% | 1,251,395 | 1,112,149 | 12.5% |
| 2020/11 | 85,536 | 110,397 | -41.6% | -22.5% | 1,180,454 | 1,015,852 | 16.2% |
| 2020/10 | 146,551 | 80,904 | 82% | 81.1% | 1,094,918 | 905,455 | 20.9% |
| 2020/09 | 80,501 | 60,617 | -24.2% | 32.8% | 948,367 | 824,550 | 15% |
久裕(4173) 歷年營收季增率
| 年度/季別 | 營收季增率 | 近4季營收季增率 | 年度/季別 | 營收季增率 | 近4季營收季增率 |
|---|---|---|---|---|---|
| 2023Q2 | 11.61% | 5.18% | 2020Q3 | -0.63% | -0.26% |
| 2023Q1 | 2.08% | 0.91% | 2020Q2 | -28.39% | 3.22% |
| 2022Q4 | -2.11% | 1.43% | 2020Q1 | 35.83% | 7.95% |
| 2022Q3 | 9.44% | 3.60% | 2019Q4 | 2.29% | -4.81% |
| 2022Q2 | -5.22% | 1.07% | 2019Q3 | 16.61% | -3.62% |
| 2022Q1 | 4.27% | 1.36% | 2019Q2 | -20.23% | -5.89% |
| 2021Q4 | 6.54% | -5.87% | 2019Q1 | -12.09% | -1.05% |
| 2021Q3 | -0.81% | -4.64% | 2018Q4 | 5.79% | 3.28% |
| 2021Q2 | -4.42% | -4.43% | 2018Q3 | 2.54% | 3.20% |
| 2021Q1 | -20.27% | -11.91% | 2018Q2 | 0.32% | 0.45% |
| 2020Q4 | 9.01% | 1.25% | 2018Q1 | 4.43% | 0.96% |
評論0